DAFTAR PUSTAKA

1. Aphrodita S. 2016. Refarat soft tissue tumor.

(https://www.academia.edu/27243296/Referat_Soft_Tissue_Tumor_Fira)
diakses november 2018.
2. Darwis I. Sarkoma jaringan lunak. Dalam: Kumpulan ilmu bedah.
Reksoprodjo S, Pusponegoro AD, Kartono D, Hutagalung ED (eds). Edisi
pertama. Jakarta: Bagian Ilmu Bedah Fakultas Kedokteran Universitas
Indonesia / RSCM. 1995. Hal: 401-405.
3. Adams GA, Garland AM, Shatney CH, Sherck JP. Sarcoma. In: Surgery
clerkship guide. 1st edition. Missouri: Mosby. 2003. p:465-468.
4. Morrison B. A. Soft tissue sarcomas of the extremities.Baylor University
medical center proceeding. Texas. 2003
5. National Comprehensive Cancer Network Clinical Practices Guidelines in
Oncology : Soft Tissue Sarcoma. 2016.
(http://www.jnccn.org/content/14/6/758.full) diakses november 2018
6. Connier J. N, Pollode R. E. Soft tissue sarcoma. A Cancer Journal for
Clinicians. 2005.
7. Darwis, Idral, dr. SpB (K) Onk., dkk, Protokol Peraboi : Protokol
Penatalaksanaan Sarkoma Jaringan Lunak (Soft Tissue Sarcoma). Bandung :
PERABOI, 2004.
8. American Cancer Society. What Is a Soft Tissue Sarcoma. 2018.
(https://www.cancer.org/cancer/soft-tissue-sarcoma/about/soft-tissue-
sarcoma.html) diakses November 2018
9. Mayo Clinic. Disease & Conditions. Soft Tissue Sarcoma. 2018.
(https://www.mayoclinic.org/diseases-conditions/soft-tissue-
sarcoma/symptoms-causes/syc-20377725) diakses November 2018
10. Burningham, Z., Hashibe, M., Spector, L., & Schiffman, J. D. The
Epidemiology of Sarcoma. Clinical Sarcoma Research. 2014.
11. Hui J.Y.C. Epidemiology and etiology of Sarcoma. University of Minnesota.
2016.
12. Froehner, M., & Wirth, M. P. Etiologic Factors in Soft Tissue Sarcomas.
Oncology Research and Treatment. 2001. Pages 139–142.
13. Helman, L. J., & Meltzer, P. Mechanisms of sarcoma development. Nature
Reviews Cancer. 2003. Pages 685–694.
14. Penel, N., Grosjean, J., Robin, Y. M., Vanseymortier, L., Clisant, S., &
Adenis, A. Frequency of Certain Established Risk Factors in Soft Tissue
Sarcoma. 2008.
15. American Society of Clinical Oncology. Sarcoma, Soft Tissue: Risk Factors.
2018. (https://www.cancer.org/cancer/soft-tissue-sarcoma/causes-risks-
prevention/risk-factors.html) diakses November 2018.
16. Martin, L. WebMD. Sarcoma. 2017.
(https://www.webmd.com/cancer/sarcoma) diakses November 2018
17. Chen, E. Pathogenesis of Sarcomas. Diagnostic Pathology- Open Access.
2016.
18. Russell, W. O., Cohen, J., Enzinger, F., Hajdu, S. I., Heise, H., Martin, R. G.,
Suit, H. D. A clinical and pathological staging system for soft tissue sarcoma.
1997.
19. Sjamsuhidajat R, de Jong W. Sistem Endokrin. Buku Ajar Ilmu Bedah. Edisi
2. Penerbit Buku Kedokteran EGC. Jakarta. 2016.
20. Casali, P. G., & Blay, J.-Y. Soft tissue sarcomas- ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2010.
21. Kotilinggam D., Raphael P., Dina C. L., Lazar A. J. Staging Soft Tissue
Sarcoma: Evolution and Change. A Cancer Journal for Clinicians.2006.
22. Grimer, R., Judson, I., Peake, D., & Seddon, B. Guidelines for the
Management of Soft Tissue Sarcomas. Sarcoma. 2010.
23. Fong Y, Coit DG, Woodruff JM, Brennan. Lymph Node Metastasis From Soft
Tissue Sarcoma in Adults. Department of Surgery and Department of
Pathology Memorial Sloan Kettering Cancer Center. New York. 1992.
24. Segal, N. H., Pavlidis, P., Antonescu, C. R., Maki, R. G., Noble, W. S.,
DeSantis, D., Cordon-Cardo, C. Classification and Subtype Prediction. 2003.
25. --- Casali, P. G., & Blay, J.-Y. Soft tissue sarcomas- ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. 2010.
26. Clark, M. A., Fisher, C., Judson, I., & Thomas, J. M. Soft-Tissue Sarcomas in
Adults. New England Journal of Medicine. 2005
27. Coindre, J. M., Trojani, M., Contesso, G., David, M., Rouesse, J., Bui, N. B.,
Goussot, J.-F. Reproducibility of a histopath. 1986.
28. Mankin, H. J., & Hornicek, F. J. Diagnosis, Classification, and Management
of Soft Tissue Sarcomas. Harvard Medical School, Boston. 2005.
29. Ramu, et al. Management of Soft-Tissue Sarcomas; Treatment Strategies,
Staging, and Outcomes. 2017.
30. Suit H. D., Phil D. Sarcoma Soft Tissue. A Cancer Journal for Clinicians.
1978.
31. ---Rosenberg S. A., Brennan M., Demos E., et All. The treatment of Soft
tissue Sarcoma. National Cancer Institue. Maryland. 1992.
32. Mullinax, J. E., Gonzalez, R. J., & Zager, J. S. (2017). Treatment of Soft
Tissue Sarcoma. Journal of the American College of Surgeons. 2017.
33. Popov, P. Soft tissue sarcomas of the lower extremity- surgical treatment and
outcome. European Journal of Surgical Oncology.2000.
34. Ratan R., Shreyaskumar P. Chemotheraphy for Soft Tissue Sarcoma. The
University of Texas MD Andreson Cancer Center. 2016.
35. Desar I., Constantinidou A., Kaal S., Jones R., Winette V. D. G. Advanced
soft tissue sarcoma and treatment option: critical appraisal of trabectedin.
2The Institute of Cancer Research and the Royal Marsden. 2016.
36. Catton C., Sullivan B., Kotwall C., Cummings B. Outcome and Prognosis in
Retroperitoneal Soft Tissue Sarcoma. Department of Surgery St. Michael
Hospital. Canada. 1994.
37. Trojan M., Contesso G., Coindre J., et all. Soft Tissue Sarcoma of Adults:
Study of Pathological Prognostic Variables and Definition of a
Histopathological Grading System. Bordeaux. 1983.
38. Eary, J. F.; O'Sullivan, F.; Powitan, Y.; Chandhury, K. R.; Vernon, C.;
Bruckner, J. D.;and Conrad, E. U. Sarcoma tumor FDG uptake measured by
PET and patient outcome a retrospective analysis. University of Washington
Medical Center. 2002.
39. Gunar Z., Matthew B., Pister P., Pollock R., et all. Prognostic Factor for
Patients with localized Soft Tissue sarcoma Treated with Conservation
Surgery and Radiation Theraphy. University of Texas M. D. Anderson Cancer
Center. 2003.